Mobile

An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of ISIS 301012 in Patients with Familial Hypercholesterolemia or Severe Hypercholesterolemia

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-003450-10

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the safety and efficacy of extended dosing with ISIS 301012 (mipomersen) in patients with familial hypercholesterolemia or severe hypercholesterolemia on concomitant lipid-lowering therapy

Critère d'inclusion

  • Patients with homozygous and heterozygous familial hypercholesterolemia or severe hypercholesterolemia

Liens